This Danaos Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Wall Street analysts change outlook on top names. See all rating changes, upgrades, downgrades and initiations at Benzinga's analyst ratings page.
Read original at benzingaStocks · News reference
Sabra Health Care REIT Q2 FFO $0.39, Inline, Sales $235.866M Beat $219.689M Estimate
Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.39 per share which met the analyst consensus estimate. This is a 5.41 percent increase over earnings of $0.37 per share from the same period last
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 3, 2026, 8:05 PM
- Checked
- Aug 3, 2026, 8:06 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Raymond James Upgrades Sabra Health Care REIT to Market Perform
Raymond James analyst David Rodgers upgrades Sabra Health Care REIT (NASDAQ:SBRA) from Underperform to Market Perform.
Read original at benzingaSabra Health Care REIT Lowers FY2026 FFO Guidance from $1.55-$1.59 to $1.53-$1.55 vs $1.55 Est
Sabra Health Care REIT (NASDAQ:SBRA) lowers FY2026 FFO guidance from $1.55-$1.59 to $1.53-$1.55 vs $1.55 analyst estimate..
Read original at benzinga